Adaptive Biotechnologies
ADPT
147 hedge funds and large institutions have $2.69B invested in Adaptive Biotechnologies in 2020 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 73 increasing their positions, 24 reducing their positions, and 22 closing their positions.
204% more repeat investments, than reductions
Existing positions increased: 73 | Existing positions reduced: 24
73% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 22
11% more funds holding
Funds holding: 133 → 147 (+14)
7.32% more ownership
Funds ownership: 69.42% → 76.74% (+7.3%)
4% more capital invested
Capital invested by funds: $2.58B → $2.69B (+$110M)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
22% less call options, than puts
Call options by funds: $2.77M | Put options by funds: $3.54M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$89.7M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$80.6M |
| 3 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$52.2M |
| 4 |
BlackRock
New York
|
+$50.3M |
| 5 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$41.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Viking Global Investors
Stamford,
Connecticut
|
-$137M |
| 2 |
MCMC
Matrix Capital Management Company
Portsmouth,
New Hampshire
|
-$61.8M |
| 3 |
SIG
Senator Investment Group
New York
|
-$48.1M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$15.9M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$12.7M |
ADPT Hedge Fund Activity: Q1 2020 in Review
147 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in Adaptive Biotechnologies (ADPT) for Q1 2020, worth a combined $2.69B — up 4.3% from $2.58B a quarter earlier.
Buyers outnumbered sellers: 38 funds opened new ADPT positions and 22 closed out — a net gain of 16 holders — while 73 added to existing stakes and 24 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $89.7M. The largest seller was Viking Global Investors, cutting an estimated $137M.
- 147 institutional investors held Adaptive Biotechnologies (ADPT) as of Q1 2020, up from 133 in Q4 2019.
- Funds reported $2.69B of Adaptive Biotechnologies stock for Q1 2020, up 4.3% quarter-over-quarter.
- 38 funds opened new Adaptive Biotechnologies positions in Q1 2020 and 22 closed out, a net change of +16 holders.
- The largest Adaptive Biotechnologies buyer in Q1 2020 was Wellington Management Group, an estimated $89.7M added.
- The largest Adaptive Biotechnologies seller in Q1 2020 was Viking Global Investors, an estimated $137M sold.
Based on aggregated 13F filings for Q1 2020.